Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer

por Asahina, H, Yamazaki, K, Kinoshita, I
Publicado 2007

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome

por Mishina, T, Dosaka-Akita, H, Kinoshita, I, Hommura, F, Morikawa, T, Katoh, H, Kawakami, Y
Publicado 1999

Predictive value of expression of p16(INK4A), retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

por Hommura, F, Dosaka-Akita, H, Kinoshita, I, Mishina, T, Hiroumi, H, Ogura, S, Katoh, H, Kawakami, Y
Publicado 1999

Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells

por Kikuchi, J, Kinoshita, I, Shimizu, Y, Oizumi, S, Nishimura, M, Birrer, M J, Dosaka-Akita, H
Publicado 2008

Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant

por Shimizu, Y, Kinoshita, I, Kikuchi, J, Yamazaki, K, Nishimura, M, Birrer, M J, Dosaka-Akita, H
Publicado 2008

Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung.

por Kinoshita, I., Dosaka-Akita, H., Shindoh, M., Fujino, M., Akie, K., Kato, M., Fujinaga, K., Kawakami, Y.
Publicado 1995

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers

por Dosaka-Akita, H, Kinoshita, I, Yamazaki, K, Izumi, H, Itoh, T, Katoh, H, Nishimura, M, Matsuo, K, Yamada, Y, Kohno, K
Publicado 2002

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

por Asahina, H, Yamazaki, K, Kinoshita, I, Sukoh, N, Harada, M, Yokouchi, H, Ishida, T, Ogura, S, Kojima, T, Okamoto, Y, Fujita, Y, Dosaka–akita, H, Isobe, H, Nishimura, M
Publicado 2006